Oxford Immunotec to Present at the Jefferies 2016 Healthcare Conference
(Thomson Reuters ONE) -
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 20, 2016 (GLOBE NEWSWIRE) --
Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics
company focused on developing and commercializing proprietary tests for the
management of immune-regulated conditions, today announced that Dr. Peter
Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial
Officer, will present at the Jefferies 2016 Healthcare Conference on Thursday,
June 9, 2016, at 2:00 p.m. ET at the Grand Hyatt in New York, NY.
A live webcast of the presentation will be available online from the investor
relations page of the Company's corporate website at www.oxfordimmunotec.com. A
webcast replay will be available approximately 24 hours after the live
presentation and will be archived on the website for approximately 60 days.
About Oxford Immunotec
Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused
on developing and commercializing proprietary tests for the management of
immune-regulated conditions. The Company's first product is the T-
SPOT(®).TB test, which is used to test for tuberculosis infection. The T-
SPOT.TB test has been approved for sale in over 50 countries, including the
United States, where it has received pre-market approval from the Food and Drug
Administration, Europe, where it has obtained a CE mark, as well as Japan and
China. The T-SPOT.CMV test and the T-SPOT.PRT test are the Company's second and
third products and part of a series of products intended for the transplantation
market. In addition to these three products, the Company has an additional six
active development programs, each of which leverages our T cell, B cell and
innate immune measuring technology. The Company is headquartered near Oxford,
U.K. and in Marlborough, Mass. Additional information can be found at
www.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.
CONTACTS:
For Media Inquiries:
Caroline Crawley
Oxford Immunotec
Tel: +44 1235 442796
ccrawley(at)oxfordimmunotec.com
For Investor Inquiries:
Rick Altieri
Chief Financial Officer
Oxford Immunotec
Tel: +1 (508) 573-9953
raltieri(at)oxfordimmunotec.com
Mark Klausner
Westwicke Partners
Tel: +1 (443) 213-0501
oxfordimmunotec(at)westwicke.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Oxford Immunotec via GlobeNewswire
[HUG#2014361]
Unternehmensinformation / Kurzprofil:
Datum: 20.05.2016 - 17:45 Uhr
Sprache: Deutsch
News-ID 472651
Anzahl Zeichen: 3152
contact information:
Town:
Oxfordshire
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 239 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Oxford Immunotec to Present at the Jefferies 2016 Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Oxford Immunotec (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
